nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Erythema—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Meropenem—Erythema—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Meropenem—Hallucination—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Meropenem—Malaise—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Meropenem—Malaise—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Meropenem—Syncope—Triamcinolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Meropenem—Syncope—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Meropenem—Oedema—Prednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Meropenem—Dysuria—Methotrexate—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Meropenem—Neutropenia—Methotrexate—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Meropenem—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Meropenem—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Meropenem—Shock—Prednisolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Meropenem—Cough—Triamcinolone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Meropenem—Tachycardia—Prednisolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Meropenem—Hypertension—Triamcinolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Meropenem—Hypertension—Methylprednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Meropenem—Pneumonia—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Meropenem—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Meropenem—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Meropenem—Infestation—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Meropenem—Renal failure—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Meropenem—Angioedema—Dexamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Meropenem—Angioedema—Betamethasone—ankylosing spondylitis	0.00231	0.00231	CcSEcCtD
Meropenem—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Meropenem—Immune system disorder—Prednisone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Meropenem—Malaise—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Meropenem—Malaise—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Meropenem—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Meropenem—Oedema—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Meropenem—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Meropenem—Syncope—Betamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Meropenem—Syncope—Dexamethasone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Meropenem—Infection—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Meropenem—Sweating—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Meropenem—Infection—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Meropenem—Shock—Triamcinolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Meropenem—Insomnia—Prednisolone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Meropenem—Shock—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Meropenem—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Meropenem—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Meropenem—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Meropenem—Erythema—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Meropenem—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Meropenem—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Meropenem—Hypertension—Dexamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Meropenem—Hypertension—Betamethasone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Meropenem—Anxiety—Dexamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Meropenem—Anxiety—Betamethasone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Meropenem—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Meropenem—Pain—Prednisolone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Meropenem—Oedema—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Meropenem—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Meropenem—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Meropenem—Oedema—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Meropenem—Insomnia—Triamcinolone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Meropenem—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Meropenem—Infection—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Meropenem—Infection—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Meropenem—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Meropenem—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Meropenem—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Meropenem—Anaemia—Prednisone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Meropenem—Shock—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Meropenem—Shock—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Meropenem—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Meropenem—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Meropenem—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Meropenem—Agitation—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Meropenem—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Meropenem—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Meropenem—Tachycardia—Betamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Meropenem—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Meropenem—Angioedema—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Meropenem—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Meropenem—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Meropenem—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Meropenem—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Meropenem—Malaise—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Meropenem—Syncope—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Meropenem—Anorexia—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Meropenem—Anorexia—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Meropenem—Urticaria—Prednisolone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Meropenem—Pain—Triamcinolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Meropenem—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Meropenem—Hypotension—Dexamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Meropenem—Hypotension—Betamethasone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Meropenem—Hypertension—Prednisone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Meropenem—Chills—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Meropenem—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Meropenem—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Meropenem—Anxiety—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Meropenem—Insomnia—Dexamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Meropenem—Insomnia—Betamethasone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Meropenem—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Meropenem—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Meropenem—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Meropenem—Erythema—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Meropenem—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Meropenem—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Meropenem—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Meropenem—Urticaria—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Meropenem—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Oedema—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Meropenem—Infection—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Meropenem—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Meropenem—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Meropenem—Back pain—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Meropenem—Shock—Prednisone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Meropenem—Pain—Betamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Meropenem—Pain—Dexamethasone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Meropenem—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Meropenem—Tachycardia—Prednisone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Meropenem—Skin disorder—Prednisone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Meropenem—Anorexia—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Meropenem—Anaemia—Methotrexate—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Meropenem—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Meropenem—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Meropenem—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Meropenem—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Meropenem—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Meropenem—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Meropenem—Malaise—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Meropenem—Urticaria—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Meropenem—Urticaria—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Meropenem—Dizziness—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Meropenem—Asthenia—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Insomnia—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Meropenem—Paraesthesia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Meropenem—Pruritus—Triamcinolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Meropenem—Cough—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Meropenem—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Meropenem—Dyspepsia—Prednisone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Meropenem—Chest pain—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Meropenem—Decreased appetite—Prednisone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Meropenem—Rash—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Meropenem—Dermatitis—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Meropenem—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Meropenem—Headache—Prednisolone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Meropenem—Constipation—Prednisone—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Meropenem—Confusional state—Methotrexate—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Meropenem—Dizziness—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Meropenem—Dizziness—Methylprednisolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Meropenem—Infection—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Meropenem—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Meropenem—Asthenia—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Meropenem—Asthenia—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Meropenem—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Meropenem—Nausea—Prednisolone—ankylosing spondylitis	0.00147	0.00147	CcSEcCtD
Meropenem—Pruritus—Betamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Meropenem—Pruritus—Dexamethasone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Meropenem—Vomiting—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Meropenem—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Meropenem—Rash—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Anorexia—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Rash—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Urticaria—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Headache—Triamcinolone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Meropenem—Headache—Methylprednisolone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Meropenem—Abdominal pain—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Meropenem—Body temperature increased—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Meropenem—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Meropenem—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Meropenem—Hypotension—Methotrexate—ankylosing spondylitis	0.0014	0.0014	CcSEcCtD
Meropenem—Dizziness—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Meropenem—Dizziness—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Meropenem—Insomnia—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Meropenem—Nausea—Triamcinolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Meropenem—Nausea—Methylprednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Meropenem—Somnolence—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Meropenem—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Meropenem—Vomiting—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Meropenem—Vomiting—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Meropenem—Rash—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Meropenem—Rash—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Meropenem—Dermatitis—Betamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Meropenem—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Meropenem—Headache—Dexamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Meropenem—Headache—Betamethasone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Meropenem—Asthenia—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Meropenem—Pain—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Meropenem—Pruritus—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Meropenem—Diarrhoea—Prednisone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Meropenem—Nausea—Dexamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Meropenem—Nausea—Betamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Meropenem—Urticaria—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Meropenem—Dizziness—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Meropenem—Vomiting—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Meropenem—Rash—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Meropenem—Dermatitis—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Meropenem—Headache—Prednisone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Meropenem—Asthenia—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Meropenem—Nausea—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Meropenem—Pruritus—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Meropenem—Dizziness—Methotrexate—ankylosing spondylitis	0.000994	0.000994	CcSEcCtD
Meropenem—Vomiting—Methotrexate—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Meropenem—Rash—Methotrexate—ankylosing spondylitis	0.000948	0.000948	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Meropenem—Headache—Methotrexate—ankylosing spondylitis	0.000942	0.000942	CcSEcCtD
Meropenem—Nausea—Methotrexate—ankylosing spondylitis	0.000893	0.000893	CcSEcCtD
